These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16186087)

  • 1. Using the EDAC test to monitor abstinence and relapses during outpatient treatment.
    Harasymiw J; Forster I; Bean P
    J Addict Dis; 2005; 24(3):101-13. PubMed ID: 16186087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using routine laboratory tests to detect heavy drinking in the general population.
    Harasymiw J; Seaberg J; Bean P
    J Addict Dis; 2006; 25(2):59-63. PubMed ID: 16785221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early detection of alcohol consumption (EDAC) score in the identification of Heavy and at-risk drinkers from routine blood tests.
    Harasymiw JW; Vinson DC; Bean P
    J Addict Dis; 2000; 19(3):43-59. PubMed ID: 11076119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new century approach for alcohol screen in the insurance industry.
    Bean P; Kleaver E; Roberts B; Harasymiw J
    J Insur Med; 2001; 33(2):183-8. PubMed ID: 11510515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence.
    Chrostek L; Cylwik B; Szmitkowski M; Korcz W
    Clin Chim Acta; 2006 Feb; 364(1-2):167-71. PubMed ID: 16087169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.
    Krampe H; Stawicki S; Wagner T; Bartels C; Aust C; Rüther E; Poser W; Ehrenreich H
    Alcohol Clin Exp Res; 2006 Jan; 30(1):86-95. PubMed ID: 16433735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.
    Bråthen G; Bjerve KS; Brodtkorb E; Helde G; Bovim G
    Alcohol Clin Exp Res; 2001 Jan; 25(1):46-53. PubMed ID: 11198714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence.
    Bean P; Harasymiw J; Peterson CM; Javors M
    Alcohol Clin Exp Res; 2001 Feb; 25(2):309-16. PubMed ID: 11236848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of alcohol misuse using a routine test panel: the early detection of alcohol consumption (EDAC) test.
    Harasymiw J; Seaberg J; Bean P
    Alcohol Alcohol; 2004; 39(4):329-35. PubMed ID: 15208166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.
    Berner MM; Bentele M; Kriston L; Mänz C; Clement HW; Härter M; Mundle G
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1372-80. PubMed ID: 16899040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
    Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
    Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of carbohydrate-deficient transferrin (CDT) in the assessment of abuse and abstinence in chronic alcoholism].
    Avivar Falcón I; Rubio Rubio JM; Leal Luna A; González Vilches J; del Trigo Espinosa MA
    An Med Interna; 2000 Nov; 17(11):572-5. PubMed ID: 11322028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
    Anton RF; Lieber C; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1215-22. PubMed ID: 12198396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of carbohydrate-deficient transferrin in alcohol-elated problems].
    Rubio Valladolid G; Martínez Ruiz M
    An Med Interna; 1997 Sep; 14(9):473-7. PubMed ID: 9453759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined use of the early detection of alcohol consumption (EDAC) test and carbohydrate-deficient transferrin to identify heavy drinking behaviour in males.
    Harasymiw J; Bean P
    Alcohol Alcohol; 2001; 36(4):349-53. PubMed ID: 11468138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study.
    Anton RF; Youngblood M
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1878-83. PubMed ID: 17067352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of contemporary biomarkers in the detection of chronic alcohol use.
    Montalto NJ; Bean P
    Med Sci Monit; 2003 Dec; 9(12):RA285-90. PubMed ID: 14646983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
    Hietala J; Koivisto H; Anttila P; Niemelä O
    Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of relapses in alcohol dependent patients using serum carbohydrate deficient transferrin: improvement with individualized reference levels.
    Borg S; Carlsson AV; Helander A; Brandt AM; Beck O; Stibler H
    Alcohol Alcohol Suppl; 1994; 2():493-6. PubMed ID: 8974373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.